Talk:Metoprolol

message: Does { { antianginals } } actually do something or can it be removed from the page? --WS 05:42, 1 August 2005 (UTC)
thread_title: antianginals

message: The article lumps together metoprolol tartrate with succinate.  The general pharmokinetics are similar, but not exactly the same.  A distinction should be made. --Tarcieri 19:59, 5 February 2006 (UTC)
replies: text: It currently says that Toprol XL is "metoprolol succinate, the sustained release formulation".  Does this mean that the succinate salt is inherently longer-lasting (like polistirex or something), or is the sustained release mechanical, like most?  The tablets are splittable, I believe... --Galaxiaad 03:00, 20 October 2007 (UTC)

text: I disagree; this is specious. Sustained-release formulations regarding "publications and legal assurance" aren't right to point to metoprolol as an autosigned preceding contribution. It's more likely that the consensus regarding syncope assurance can be deemed legal on the grounds of effective indicative removals.  —Preceding unsigned comment added by 99.2.210.75 (talk) 09:43, 13 April 2009 (UTC)
thread_title:  Inaccuracies 

message: why remove the various generic names of the drug?  i think it's useful information.
—Preceding unsigned comment added by Drues (talk • contribs)  03:45, 21 July 2006 
:Because they are, except in rare cases, not WP:Notable (they have not developed the drug, undertaken any of teh original research into the underlying condition for which it is used & so treated, pushed & marketed for its use). Generics are presecribed by the INN (or USAN) name, not the generic name (otherwise this would be brand-prescribing) and so it is of little consequence which brand the patient finds their local pharamcy has decided to stock with (specifying brands for antiepileptic medication, slow-release isodorbide mono- or di- nitrates, lithium and a few others are truely not bio-equivalent). David Ruben  Talk  15:11, 21 July 2006 (UTC)
replies: text: Though it is not relevant to the inclusion vs exclusion of generic names, I would note, this pharma household, with one each on the discovery and clinical sides, regularly checks generic provider information for FDA warning letters, and other indications that the chosen generic provider is not fully trustworthy. That is to say, this informed household disagrees with the statement above, "it is of little consequence which brand the patient finds their local pharamcy has decided to stock". A careful look sometimes clearly indicates otherwise. 2601:240:CD08:7E53:F835:D486:4EB3:C118 (talk) 18:05, 16 November 2022 (UTC)
thread_title: Removal of generic names

message: Should this be mentioned?
Patent information is historical and should be reported in my opinion. 192.147.67.12 19:22, 13 October 2006 (UTC)
thread_title:  Patent expired? 

message: The reference wasn't the best on my initial entry, but here again from a paper by JAAC. Unless somebody believes that's a an unreliable source...(Osterluzei (talk) 14:07, 20 February 2014 (UTC)
thread_title:  Ok then on maintaining sinus rhythm

message: I once took 50Mg per day and now 25. After reading the side affects I'd like to go lower. It would be good to know what's available.  — Preceding unsigned comment added by 24.239.153.52 (talk) 16:27, 13 October 2015 (UTC)
thread_title:  Dosages 

message: I am removing ataxia from the adverse effects section. I take metoprolol and have developed ataxia so I am personally motivated to find a link. After reviewing medical journals and scholarly papers I can't find any indication of a link between the two except very weak anecdotal information. In fact there are papers discussing the use of metoprolol in treating tremors and thereby improving some ataxias. Normally I would place a Citation Needed notice up but I feel the information is so incorrect that it needs immediate editing. I truly hope someone can replace it with a verifiable WP:V citation.Mensch (talk) 14:42, 25 September 2017 (UTC)
thread_title:  Adverse Effects 

message: As a source is perfectly fine. Doc James (talk · contribs · email) 16:33, 20 March 2020 (UTC)
thread_title: [[American Society of Health-System Pharmacists]]

message: The redirect Dutoprol has been listed at redirects for discussion to determine whether its use and function meets the redirect guidelines. Readers of this page are welcome to comment on this redirect at  until a consensus is reached.  — CrafterNova [ TALK ] [ CONT ] 16:57, 11 April 2023 (UTC)
thread_title:  "[[:Dutoprol]]" listed at [[Wikipedia:Redirects for discussion|Redirects for discussion]]